BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
スポンサーリンク
概要
- 論文の詳細を見る
- 2005-07-15
著者
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
KIYOI Hitoshi
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
ASOU Norio
Department of Hematology, Kumamoto University School of Medicine
-
EMI Nobuhiko
Department of Hematology, Fujita Health University
-
KOHNO Akio
Department of Hematology and Oncology JA Aichi Konan Kosei Hospital
-
SAWA Masashi
Department of Hematology, Anjo Kosei Hospital
-
SHIMOYAMA Masanori
National Cancer Center Hospital
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
Maeda S
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Miura S
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
Seto M
Department Of Hematology And Chemotherapy
-
Seto Masao
東京大学医学部附属病院 無菌治療部
-
Seto M
Aichi Cancer Center Res. Inst. Nagoya
-
HAMAJIMA Nobuyuki
Department of Preventive Medicine/Biostatistics and Medical Decision Making, Nagoya University Gradu
-
KURIYAMA Kazutaka
Nagasaki CML Study Group
-
Kato T
Department Of Gastroenterological Surgery Aichi Cancer Center Hospital
-
Kagami Y
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Hatsumi Naoko
Japan Adult Leukemia Study Group Hamamatsu Jpn
-
Yokozawa Toshiya
豊橋市民病院 血液･腫瘍内科
-
Yokozawa Toshiya
Clinical Research Center National Hospital Organization Nagoya Medical Center
-
Yokozawa T
Nagoya Univ. Graduate Schol Of Medicine Nagoya Jpn
-
Yokozawa T
Hematology Division National Cancer Center Hospital
-
Yokozawa Toshiya
Department Of Hematology Nagoya University Graduate School Of Medicine
-
Yokozawa Toshiya
Division Of Hematology Nagoya Medical Center
-
Kagami Yoshitoyo
名古屋大学医学部附属病院 病理部
-
ITOH Yoshie
Department of Hospital Pharmacy, School of Medicine, Kanazawa University
-
KIYOI Hitoshi
Nagoya University Hospital
-
KITAMURA Kunio
Department of Hematology, Ichinomiya Municipal Hospital
-
YAMAMOTO Kazuhito
Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital
-
HISHIDA Asahi
Department of Molecular Medicine and Hematology, Nagoya University Graduate School of Medicine
-
KAJIGUCHI Tomohiro
Department of Molecular Medicine and Hematology, Nagoya University Graduate School of Medicine
-
SETO Masao
Division of Molecular Medicine, Aichi Cancer Center Research Institute
-
Kohno Akio
愛知県厚生連昭和病院
-
Kohno Akio
Division Of Hematology And Oncology Ja Aichi Showa Hospital
-
Kohno A
Nagoya Univ. School Of Medicine Nagoya Jpn
-
Kitamura Kunio
名古屋大学 医学系研究科血液･腫瘍内科学
-
Yamamoto Kazuhito
Department Of Hematology And Cell Therapy Aichi Cancer Center Hospital
-
Shimoyama M
Department Of Hematology Anjo Kosei Hospital
-
Sawa Masashi
Department Of Molecular Medicine And Hematology Nagoya University Graduate School Of Medicine
-
Kiyoi Hitoshi
豊橋市民病院 血液･腫瘍内科
-
Kosugi H
Department Of Hematology Ogaki Municipal Hospital
-
Kiyoi Hitoshi
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Kajiguchi Tomohiro
Department Of Hematology Nagoya University Graduate School Of Medicine
-
Kanakura Yuzuru
大阪大学 医学系研究科心臓血管外科
-
Hishida Asahi
Department Of Hematology Nagoya University Graduate School Of Medicine
-
Hishida Asahi
名古屋大学 医学系研究科予防医学
-
Asou Norio
愛知県がんセンター
-
Asou N
Department Of Hematology Kumamoto University School Of Medicine
-
Asou Norio
Department Of Pathology And Molecular Diagnostics Aichi Cancer Center
-
Asou Norio
Department Of Hematology And Infectious Diseases Kumamoto University Graduate School Of Medical Scie
-
Kuriyama K
Blood Immunology Laboratory School Of Health Sciences Faculty Of Medicine And University Hospital Un
-
Kato Koji
Department Of Hematology Aomori Prefectural Central Hospital
-
Hamajima N
Department Of Preventive Medicine-biostatistics And Medical Decision Making Nagoya University Gradua
-
Hamajima Nobuyuki
愛知県がんセンター研究所 疫学･予防部
-
Hamajima Nobuyuki
Department Of Preventive Medicine/biostatistics And Medical Decision Making Nagoya University Gradua
-
Seto Masao
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
Kunitomi Akane
名鉄病院 血液内科
-
SANO Masayuki
Departments of Internal Medicine Saga Medical School
-
Kawase Yoshiaki
Department Of Internal Medicine Japanese Red Cross Nagoya First Hospital
-
Sakai Mari
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Kuroishi Tetsuo
愛知県がんセンター研究所
-
Kuroisi Tetsuo
The Division Of Epidemiology And Prevention Aichi Cancer Center Research Institute
-
Sano Masayuki
Niigata Cancer Center Hospital
-
Asou Norio
Department Of Hematology Kumamoto University School Of Medicine
-
Emi Nobuhiko
名古屋大学 医学系研究科血液･腫瘍内科学
-
Emi Nobuhiko
First Department Of Internal Medicine Nagoya University Graduate School Of Medicine
-
Emi Nobuhiko
The First Department Of Internal Medicine Nagoya University School Of Medicine
-
Hamajima Nobuyuki
Department Of Preventive Medicine Aichi Cancer Center Research Institute
-
Hamajima Nobuyuki
Cancer Information Service And Surveillance Division Cancer For Cancer Control And Information Servi
-
Hamajima Nobuyuki
Department Of Preventive Medicine
-
Kuroishi Tetsuo
Division Of Epidemiology And Prevention Aichi Cancer Center Research Institute Aichi Cancer Center H
-
Shamoto M
Fujita Health Univ. Toyoake Jpn
-
Minami S
Nagasaki Cml Study Group
-
Matsuda Shin
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Takemoto Yoshinobu
Department Of Pathology Okayama University Medical School
-
Asou Norio
Department Of Internal Medicine Ii Kumamoto University School Of Medicine
-
Naoe Tomoki
Department Of Hematologly And Oncology Nagoya University School Of Medicine
-
Kohno Akio
First Department Of Internal Medicine Nagoya University School Of Medicine
-
Miura Shigeto
Department Of Breast Surgery Aichi Cancer Center Hospital
-
Sano Muneaki
Department Of Surgery Niigata Cancer Center
-
Mori Shin‐ichiro
Hematopoietic Stem Cell Transplantation Division National Cancer Center Hospital
-
Kosugi Hiroshi
Institute For Chemical Research Tohoku University
-
Shirai Masato
Department Of Gastroenterology Aichi Cancer Center Hospital
-
Seto Masao
Division Of Molecular Medicine Aichi Cancer Center
-
Kagami Yoshitoyo
Department Of Pathology School Of Medicine Kurume University
-
Koshikawa Takashi
Aichi Prefectural College Of Nursing & Health
-
Hoki Noriyuki
Department Of Gastroenterology Aichi Cancer Center Hospital
-
Hamajima N
Department Of Preventive Medicine Biostatistics And Medical Decision Making Nagoya University Gradua
-
Kawa Keisei
Department Of Hematology Aomori Prefectural Central Hospital
-
Mori Shigeo
Hematopoietic Stem Cell Transplantation Division National Cancer Center Hospital
-
Yokozawa Toshiya
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Emi N
Department Of Hematology Nagoya University Graduate School Of Medicine
-
Itoh Yoshie
Department Of Hematology Gifu Prefectural Tajimi Hospital
-
Yano Kunio
県西部浜松医療センター
-
Seto Masao
Department Of Hematology/oncology Nagoya National Hospital
-
Hirabayashi Noriyuki
Department Of Hematology Nagoya Daini Red Cross Hospital
-
Kitamura Kunio
Department Of Hematology Ichinomiya Municipal Hospital
-
Hishida Asahi
Division Of Epidemiology And Prevention Aichi Cancer Center Research Institute
-
Moritaka S
Department Of Surgery Ii Nagoya City University Medical School
-
Emi Nobuhiko
Department Of Hematology And Clinical Oncology Fujita Health University School Of Medicine
-
Miura Shigeto
Department Of Surgery Aichi Cancer Center
-
Asano Naoko
Department Of Laboratory Medicine Shinshu University Hospital
-
Asano Naoko
Department Of Pathology And Molecular Diagnostics Aichi Cancer Center
-
Hiraki Akio
Department Of Gynecology And Obstetrics Nagoya University Graduate School Of Medicine
-
Yamamoto Kazuhito
Department Of Gastroenterology Aichi Cancer Center Hospital
-
Hatsumi Naoko
Leukemia Research Center Saiseikai Maebashi Hospital
-
Suzuki Masumi
Department Of Thoracic Surgery Aichi Cancer Center Hospital
-
Nakano Tatsunori
Second Departmant Of Medicine Nagoya City University Medical School
-
Fukushima Takuya
Department Of Hematology Nagasaki University Hospital
-
Hamajima Nobuyuki
Department of Epidemiology and Public Health, Kanazawa Medical University
-
SAWA Masashi
Department of Hematology and Oncology, Anjo Kosei Hospital
関連論文
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Promoter Hypermethylation of the DNA-Repair Gene O^6-Methylguanine-DNA Methyltransferase and p53 Mutation in Diffuse Large B-Cell Lymphoma
- Loss of O^6-Methylguanine-DNA Methyltransferase Protein Expression Is a Favorable Prognostic Marker in Diffuse Large B-Cell Lymphoma
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- Donor cell leukemia after allogeneic peripheral blood stem cell transplantation : a case report and literature review
- Unrelated-Donor Bone Marrow Transplantation with a Conditioning Regimen Including Fludarabine, Busulfan, and 4 Gy Total Body Irradiation
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Definite diagnosis in Japanese patients with protein C deficiency by identification of causative PROC mutations
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy
- Mutational analysis of SOS1 gene in acute myeloid leukemia
- Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan
- Evaluation of organ involvement in intravascular large B-cell lymphoma by ^F-fluorodeoxyglucose positron emission tomography
- Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis
- Sustained Remission after Rituximab-containing Chemotherapy for Intravascular Large B-cell Lymphoma
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia
- Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy
- BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
- Successful Treatment with Imatinib Mesylate of a CML Patient in Megakaryoblastic Crisis with Severe Fibrosis
- Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
- Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer : Japan Clinical Oncology Group study, JCOG 9208
- No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
- Safety and Efficacy of Autologous Progenitor Cell Transplantation for Therapeutic Angiogenesis in Patients With Critical Limb Ischemia
- Downregulation of microRNAs-143 and -145 in B-cell malignancies
- let-7 MicroRNA Functions as a Potential Growth Suppressor in Human Colon Cancer Cells(Molecular and Cell Biology)
- A Case of Interstitial Pneumonia Induced by Rituximab Therapy
- Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
- Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult oatients with acute lymphoblastic leukemia: The ALL-87 Study of the Japan Adult Leukemia Study Group (JALSG)
- Chemical Speciation of Arsenic Species in Human Blood Serum by Liquid Chromatography Using a Phosphatidylcholine-Coated ODS Column with Detection by ICP-MS
- Senile Epstein-Barr Virus-Associated B-Cell Lymphoproliferative Disorders : a Mini Review
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
- Establishment of a Stroma-Dependent Human Acute Myelomonocytic Leukemia Cell Line, NAMO-2, with FLT3 Tandem Duplication
- Recurrent Intramural Hematoma of the Small Intestine in a Severe Hemophilia A Patient with a High Titer of Factor VIII Inhibitor : A Case Report and Review of the Literature
- High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation
- Apoptotic Cytotoxic Effects of a Histone Deacetylase Inhibitor, FK228, on Malignant Lymphoid Cells
- Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
- Conditioning Regimen of Melphalan, Fludarabine and Total Body Irradiation in Unmanipulated HLA Haploidentical Stem Cell Transplantation Based on Feto-maternal Tolerance
- Adenocarcinomatosis of the Bone Marrow and Secondary Acute Myeloid Leukemia
- Primary Cutaneous Diffuse Large B Cell Lymphoma : A Clinically Aggressive Case
- Interaction of von Willebrand Factor with the Extracellular Matrix and Glycocalicin under Static Conditions^1
- Hairy cell leukemia responsive to anti-thymocyte globulin used as immunosuppressive therapy for aplastic anemia
- Long-term Follow-up of 14 Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia following Autologous Bone Marrow Transplantation in First Complete Remission
- Recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia
- Spontaneous regression of aleukemic leukemia cutis harboring a NPM/RARA fusion gene in an infant with cutaneous mastosytosis
- Biology, Clinical Relevance, and Molecularly Targeted Therapy in Acute Leukemia with FLT3 Mutation
- Nucleophosmin : A versatile molecule associated with hematological malignancies
- Mechanism-based Therapy for Leukemia: A Lesson from Atra Therapy
- Karyotypically independent clones with del(11q) and trisomy 10 in acute myeloid leukemia : trisomy 10 may appear as an additional change
- Antitumor effect of arsenic trioxide in murine xenograft model
- Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype
- Stable Engraftment after a Conditioning Regimen with Fludarabine and Melphalan for Bone Marrow Transplantation from an Unrelated Donor
- Quality of Life in Adult Patients after Bone Marrow Transplantation
- Irrespective of CD34 expression, lineage-committed cell fraction reconstitutes and re-establishes transformed Philadelphia chromosome-positive leukemia in NOD/SCID/IL-2Rγc^ mice
- Low-Dose Cyclosporin A with Short-Term Methotrexate for Graft-versus-Host Disease Prophylaxis in Allogeneic Bone Marrow Transplantation from Human Leukocyte Antigen-Identical Siblings : A Prospective Phase II Study in Japanese Patients
- Severe hemophilia A in a Japanese female caused by an F8-intron 22 inversion associated with skewed X chromosome inactivation
- Classic Polyarteritis Nodosa Presenting Rare Clinical Manifestations in a Patient with Hemophilia A
- Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1
- Ectopic Expression of MAFB Gene in Human Myeloma Cells Carrying (14;20)(q32;q11) Chromosomal Translocations
- Acute myeloid leukemia in the elderly : 159 Nagoya case studies
- Intestinal Diffuse Large B-Cell Lymphoma Associated with Celiac Disease : A Japanese Case
- Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines
- Primary cutaneous T-cell lymphoma of unspecified type with cytotoxic phenotype : Clinicopathological analysis of 27 patients
- Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders : Special references to lymphomas surrounding this newly recognized clinicopathologic disease
- Successful treatment of Aspergillus liver abscesses in a patient with acute monoblastic leukemia using combination antifungal therapy including micafungin as a key drug
- Micafungin-induced immune hemolysis attacks
- Long-term Efficacy of Pegylated Recombinant Human Megakaryocyte Growth and Development Factor in Therapy of Aplastic Anemia
- Two Cases Showing Clonal Progression With Full Evolution From Aplastic Anemia-Paroxysmal Nocturnal Hemoglobinuria Syndrome to Myelodysplastic Syndromes and Leukemia
- CD4- and CD56-positive T-cell line MTA, established from natural killer-like T-cell leukemia/lymphoma
- Oral Melphalan, Dexamethasone, and Thalidomide for the Treatment of Refractory Multiple Myeloma
- Mesenchymal Stem Cells Isolated from Frozen Bone Marrow Have Multilineage Potency
- Toxic effects of arsenic (As^) and other metal ions on acute promelocytic leukemia cells
- Immunoglobulin Variable Region Structure and B-Cell Malignancies
- Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin's lymphoma with two topoisomerase II inhibitors, MST-16 and VP-16
- Immunoaffinity Purification and Characterization of CACGTG Sequence-Binding Proteins from Cultured Mammalian Cells Using an Anti c-Myc Monoclonal Antibody Recognizing the DNA-Binding Domain
- Age-related EBV-associated B-cell lymphoproliferative disorders : Diagnostic approach to a newly recognized clinicopathological entity
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Expanded distribution of the T315I mutation among hematopoietic stem cells and progenitors in a chronic myeloid leukemia patient during imatinib treatment
- Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemia
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Virus-Associated Hemophagocytic Syndrome Caused by Pandemic Swine-Origin Influenza A (H1N1) in a Patient After Unrelated Bone Marrow Transplantation
- Mismatched human leukocyte antigen class II-restricted CD8^+ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance : sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisis
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation : macrophage-targeted steroid therapy
- Mutation of ARHGAP9 in patients with coronary spastic angina
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study
- Efficacy and safety of human adipose tissue-derived mesenchymal stem cells for supporting hematopoiesis
- Guest editorial : Introducing progress in hematology in this issue
- Micafungin for empirical antifungal therapy in patients with febrile neutropenia: multicenter phase 2 study